INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Connecticut. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | Conn. Gen. Stat. §§ 20-14q, 21a-70g (P.A. 16-214)“A manufacturer of an investigational drug, biological product or device, as defined in section 20-14q , may make available the manufacturer's investigational drug, biological product or device to a patient who is eligible under subsection (b) of section 20-14q” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2016 | P.A. 16-214 (S.B. 371, 2016), 'An Act Concerning the Use of Experimental Drugs'“Bill History Date Action Taken 6/10/2016 Signed by the Governor”Note: Signed June 10, 2016; statute history notes for 20-14q and 21a-70g read '(P.A. 16-214, S. 1.)' / 'S. 2.'. Stored 2018 is wrong. | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | do not require individualized approval | Goldwater Institute list of states enacting Right to Try for Individualized Treatments (as of May 30, 2025)“The Lone Star State is now the fifteenth state since 2022 to champion this crucial expansion, joining Colorado, Iowa, Louisiana, Indiana, Georgia, Maryland, Mississippi, Arizona, Nevada, North Carolina, Arkansas, Tennessee, Kansas and South Dakota” | Link | 2026-10-09 | medium |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | Conn. Gen. Stat. § 21a-70g(b)“Nothing in this section shall create a cause of action against a manufacturer of an investigational drug, biological product or device that makes available such investigational drug, biological product or device to an eligible patient for any harm done to such patient”Note: 'No cause of action' clause (not an immunity); section title 'Liability of manufacturer'. No good-faith or reasonable-care qualifier in the text. 20-14q(f) gives a parallel clause for the treating physician and others involved in care. Stored FALSE is wrong. | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | Conn. Gen. Stat. § 20-14q(c)(5)“states clearly that the patient's health carrier, as defined in section 38a-510c , treating physician or other health care provider is not obligated to pay for any care or treatments resulting from the use of the investigational drug, biological product or device” | Link | 2026-10-09 | high |
View full Connecticut profile (all layers) · Report an error on this page